However, S100A8, LAG3, CXCL10, CXCL9 and BIRC5 showed a difference in fold change between DCIS and invasive carcinoma although statistically not significant (adjusted p value > 0.05; Supplementary Table S1). Here, BIRC5 is linked to ductal breast carcinoma in situ.